دورية أكاديمية
Empowerment-based nutrition interventions on blood pressure: a randomized comparative effectiveness trial.
| العنوان: | Empowerment-based nutrition interventions on blood pressure: a randomized comparative effectiveness trial. |
|---|---|
| المؤلفون: | Moreira-Rosário A; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Ismael S; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Barreiros-Mota I; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Morais J; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Rodrigues C; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Castela I; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Mendes IC; CUF Academic and Research Medical Center, Lisbon, Portugal., Soares MI; CUF Academic and Research Medical Center, Lisbon, Portugal., da Costa LS; CUF Academic and Research Medical Center, Lisbon, Portugal., Oliveira CB; CUF Academic and Research Medical Center, Lisbon, Portugal., Henriques T; CUF Academic and Research Medical Center, Lisbon, Portugal., Pinto P; CUF Academic and Research Medical Center, Lisbon, Portugal., Pita D; CUF Academic and Research Medical Center, Lisbon, Portugal., de Oliveira CM; CUF Academic and Research Medical Center, Lisbon, Portugal., Maciel J; CUF Academic and Research Medical Center, Lisbon, Portugal., Serafim T; CUF Academic and Research Medical Center, Lisbon, Portugal., Araújo J; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Rocha JC; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Pestana D; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Silvestre MP; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Marques C; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Faria A; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CHRC, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal., Polonia J; Department of Community Medicine, Information and Health Decision Sciences (MEDCIDS), Faculty of Medicine, University of Porto, Porto, Portugal.; CINTESIS@RISE, Faculty of Medicine, University of Porto, Porto, Portugal.; Hypertension and Cardiovascular Risk Unit, Unidade Local de Saúde Matosinhos, Matosinhos, Portugal., Calhau C; NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal.; CINTESIS@RISE, NOVA Medical School, Faculdade de Ciências Médicas, NMS, FCM, Universidade Nova de Lisboa, Lisbon, Portugal. |
| المصدر: | Frontiers in public health [Front Public Health] 2023 Nov 13; Vol. 11, pp. 1277355. Date of Electronic Publication: 2023 Nov 13 (Print Publication: 2023). |
| نوع المنشور: | Randomized Controlled Trial; Journal Article; Research Support, Non-U.S. Gov't |
| اللغة: | English |
| بيانات الدورية: | Publisher: Frontiers Editorial Office Country of Publication: Switzerland NLM ID: 101616579 Publication Model: eCollection Cited Medium: Internet ISSN: 2296-2565 (Electronic) Linking ISSN: 22962565 NLM ISO Abbreviation: Front Public Health Subsets: MEDLINE |
| أسماء مطبوعة: | Original Publication: Lausanne : Frontiers Editorial Office |
| مواضيع طبية MeSH: | Hypertension*/prevention & control, Adult ; Humans ; Middle Aged ; Blood Pressure ; Sodium Chloride, Dietary ; Outcome Assessment, Health Care |
| مستخلص: | Introduction: Empowerment lifestyle programs are needed to reduce the risk of hypertension. Our study compared the effectiveness of two empowerment-based approaches toward blood pressure (BP) reduction: salt reduction-specific program vs. healthy lifestyle general program. Methods: Three hundred and eleven adults (median age of 44 years, IQR 34-54 years) were randomly assigned to a salt reduction ( n = 147) or a healthy lifestyle program ( n = 164). The outcome measures were urinary sodium (Na + ) and potassium (K + ) excretion, systolic (SBP) and diastolic (DBP) blood pressure, weight, and waist circumference. Results: There were no significant differences in primary and secondary outcomes between the two program groups. When comparing each program to baseline, the program focused on salt reduction was effective in lowering BP following a 12-week intervention with a mean change of -2.5 mm Hg in SBP (95% CI, -4.1 to -0.8) and - 2.7 mm Hg in DBP (95% CI, -3.8 to -1.5) in the intention-to-treat (ITT) analysis. In the complete-case (CC) analysis, the mean change was -2.1 mm Hg in SBP (95% CI, -3.7 to -0.5) and - 2.3 mm Hg in DBP (95% CI, -3.4 to -1.1). This effect increases in subjects with high-normal BP or hypertension [SBP - 7.9 mm Hg (95% CI, -12.5 to -3.3); DBP - 7.3 mm Hg (95% CI, -10.2 to -4.4)]. The healthy lifestyle group also exhibited BP improvements after 12 weeks; however, the changes were less pronounced compared to the salt reduction group and were observed only for DBP [mean change of -1.5 mm Hg (95% CI, -2.6 to -0.4) in ITT analysis and - 1.4 mm Hg (95% CI, -2.4 to -0.3) in CC analysis, relative to baseline]. Overall, improvements in Na + /K + ratio, weight, and Mediterranean diet adherence resulted in clinically significant SBP decreases. Importantly, BP reduction is attributed to improved dietary quality, rather than being solely linked to changes in the Na + /K + ratio. Conclusion: Salt-focused programs are effective public health tools mainly in managing individuals at high risk of hypertension. Nevertheless, in general, empowerment-based approaches are important strategies for lowering BP, by promoting health literacy that culminates in adherence to the Mediterranean diet and weight reduction. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2023 Moreira-Rosário, Ismael, Barreiros-Mota, Morais, Rodrigues, Castela, Mendes, Soares, da Costa, Oliveira, Henriques, Pinto, Pita, de Oliveira, Maciel, Serafim, Araújo, Rocha, Pestana, Silvestre, Marques, Faria, Polonia and Calhau.) |
| References: | Curr Pharm Des. 2016;22(7):859-69. (PMID: 26648468) Health Promot Int. 2016 Dec;31(4):809-826. (PMID: 26137970) Eur J Nutr. 2019 Feb;58(1):173-191. (PMID: 29177567) Am J Clin Nutr. 2020 Dec 10;112(6):1584-1598. (PMID: 33022695) Nutrients. 2020 May 29;12(6):. (PMID: 32486102) Int J Behav Nutr Phys Act. 2019 Jul 30;16(1):58. (PMID: 31362753) J Nutr. 2011 Jun;141(6):1140-5. (PMID: 21508208) Fam Community Health. 2014 Apr-Jun;37(2):104-18. (PMID: 24569157) Eval Health Prof. 2018 Sep;41(3):351-392. (PMID: 29172696) J Transl Med. 2017 Apr 24;15(1):81. (PMID: 28438173) Public Health Nutr. 2021 Jun;24(9):2746-2757. (PMID: 32744196) Clin Nutr. 2021 May;40(5):3191-3200. (PMID: 33581952) Blood Press Monit. 2008 Feb;13(1):49-54. (PMID: 18199924) Public Health Nutr. 2015 Dec;18(17):3146-54. (PMID: 25686640) High Blood Press Cardiovasc Prev. 2021 Nov;28(6):547-553. (PMID: 34533781) J Am Heart Assoc. 2020 Oct 20;9(19):e016804. (PMID: 32975166) Nutrients. 2020 May 16;12(5):. (PMID: 32429342) J Hypertens. 2023 Dec 1;41(12):1874-2071. (PMID: 37345492) J Hypertens. 2013 Jul;31(7):1281-357. (PMID: 23817082) Adv Nutr. 2020 Sep 1;11(5):1150-1160. (PMID: 32330233) Can J Public Health. 1986 Nov-Dec;77(6):425-30. (PMID: 3580992) Hypertension. 2003 Nov;42(5):878-84. (PMID: 12975389) Cardiovasc Res. 2001 Dec;52(3):361-71. (PMID: 11738053) J Hypertens. 2017 Mar;35(3):477-486. (PMID: 27898506) Health Promot Int. 2014 Jun;29(2):378-88. (PMID: 21903686) Crit Rev Food Sci Nutr. 2019;59(16):2674-2687. (PMID: 29718689) Mini Rev Med Chem. 2013 Jun 1;13(8):1137-49. (PMID: 22931531) Eur J Prev Cardiol. 2022 Feb 19;29(1):5-115. (PMID: 34558602) Nutrients. 2013 Sep 17;5(9):3646-83. (PMID: 24067391) Nutrients. 2019 Sep 16;11(9):. (PMID: 31527400) Lancet. 2019 Feb 2;393(10170):447-492. (PMID: 30660336) J Nutr. 2009 Apr;139(4):743-9. (PMID: 19211830) Eur J Clin Nutr. 2022 Feb;76(2):179-183. (PMID: 34006993) Clin Nutr. 2009 Feb;28(1):10-4. (PMID: 18834651) Am J Clin Nutr. 2017 Jun;105(6):1305-1313. (PMID: 28424187) J Hypertens. 2021 Jul 1;39(7):1293-1302. (PMID: 33710173) J Hypertens. 2014 Jun;32(6):1211-21. (PMID: 24675681) J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021. (PMID: 33309175) |
| فهرسة مساهمة: | Keywords: blood pressure; cardiovascular diseases; hypertension; mediterranean diet; sodium/potassium ratio |
| سلسلة جزيئية: | ClinicalTrials.gov NCT03830021 |
| المشرفين على المادة: | 0 (Sodium Chloride, Dietary) |
| تواريخ الأحداث: | Date Created: 20231129 Date Completed: 20231201 Latest Revision: 20240428 |
| رمز التحديث: | 20240429 |
| مُعرف محوري في PubMed: | PMC10679749 |
| DOI: | 10.3389/fpubh.2023.1277355 |
| PMID: | 38026295 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2296-2565 |
|---|---|
| DOI: | 10.3389/fpubh.2023.1277355 |